Universal influenza vaccination and live attenuated influenza vaccination of children

Pediatric Infectious Disease Journal

Volumn 27, Issue SUPPL. 10, 2008, Pages

  Glezen, W Paul ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Children; Influenza vaccine; Live attenuated influenza vaccine

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; EPIDEMIC; HERD IMMUNITY; HUMAN; INFANT; INFLUENZA; MASS IMMUNIZATION; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; STATISTICS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; IMMUNITY, HERD; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; MASS IMMUNIZATION; MIDDLE AGED; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 56149104634     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318168b729     Document Type: Conference Paper

References (24)

1. Couch RB, Kasel JA, Glezen WP, et al. Influenza: its control in persons and populations. J Infect Dis. 1986;153:431-440. (Pubitemid 16106228)
2. Glezen WP, Decker M, Joseph SW, Mercready RG Jr. Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983. J Infect Dis. 1987;155:1119-1126. (Pubitemid 17080484)
3. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev. 1982;4:25-43.
4. Glezen WP, Couch RB. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med. 1978;298:587-592. (Pubitemid 8291640)
5. Gruber WC, Taber LH, Glezen WP, et al. Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child. 1990; 144:595-600. (Pubitemid 20153420)
6. Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis. 1991;163:300-304.
7. Piedra PA, Glezen WP. Influenza in children: epidemiology, immunity, and vaccines. Semin Pediatr Infect Dis. 1991;2:140-146.
8. Glezen WP. Asthma, influenza, and vaccination. J Allergy Clin Immunol. 2006;118:1199-1206. (Pubitemid 44854128)
9. Ashkenazi S, Vertruyen A, Aristegui J, et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J. 2006;25:870-879. (Pubitemid 44510578)
10. Piedra PA, Gaglani MJ, Riggs M, et al. Live attenuated influenza vaccine, trivalent is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial. Pediatrics. 2005;116:e397-e407. (Pubitemid 44339432)
11. Fleming DM, Crovari P, Wahn U, et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J. 2006;25:860-869. (Pubitemid 44510577)
12. Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007;356:685-696.
13. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med. 1998;338:1405-1412. (Pubitemid 28221981)
14. Gaglani MJ, Piedra PA, Herschler GB, et al. Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. Arch Pediatr Adolesc Med. 2004;158:65-73. (Pubitemid 38036634)
15. Halloran ME, Longini IM Jr, Gaglani MJ, et al. Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A(H1N1) and B using surveillance cultures. Am J Epidemiol. 2003;158:305-311. (Pubitemid 41288797)
16. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-related illnesses with the use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine. 2005;23: 1540-1548. (Pubitemid 40203391)
17. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Live attenuated intranasal influenza vaccine-trivalent (LAIV-T) administered during the 2003-04 influenza type A(H3N2) outbreak provided immediate, direct and indirect protection in children. Pediatrics. 2007;120:e553-e564. (Pubitemid 47358268)
18. Halloran ME, Piedra PA, Longini IM Jr, et al. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A(Fujian), a drift variant, during 2003-2004. Vaccine. 2007;25:4038-4045. (Pubitemid 46628989)
19. Glezen WP. Herd protection against influenza. J Clin Virol. 2006;37: 237-243. (Pubitemid 44755286)
20. Monto AS, Davenport FM, Napier A, Francis T Jr. Effect of vaccination of a school-age population upon the course of an A2/Hong Kong influenza epidemic. Bull World Health Organ. 1969;41:537-542.
21. Rudenko LG, Slepushkin AN, Monto AS, et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod Russia. J Infect Dis. 1993;168:881-887. (Pubitemid 23282559)
22. Hurwitz ES, Haber M, Chang A, et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA. 2000;284:1677-1682.
23. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med. 2001;344:889-896. (Pubitemid 32224397)
24. Ghendon YZ, Kaira AN, Elshina GA. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol Infect. 2006;134:71-78. (Pubitemid 43103531)